दवाओं की अंतःक्रिया
Exenatide injectable + Insulin glargine-lixisenatide
गंभीरता: गंभीर
Exenatide injectable and Insulin glargine-lixisenatide: major interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Both products are GLP-1 receptor agonists (lixisenatide in the fixed-dose combination and exenatide), so combining them duplicates therapy without a proven added benefit. Gastrointestinal adverse effects, and hypoglycemia from the insulin component, may be increased.
इस इंटरैक्शन का सरल भाषा में अर्थ
Exenatide injectable and Insulin glargine-lixisenatide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
ऐसा क्यों होता है
Duplicate GLP-1 receptor agonist activity producing additive pharmacodynamic effects on insulin secretion, gastric emptying and appetite.
क्या करें
Avoid using two GLP-1 receptor agonists together; choose a single agent and stop the duplicate. If the combination is unavoidable, monitor blood glucose and GI tolerability closely and reduce insulin as needed.
फार्मासिस्ट से क्या पूछें
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Exenatide injectable और Insulin glargine-lixisenatide की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Insulin glargine-lixisenatide के अन्य इंटरैक्शन
अक्सर पूछे जाने वाले प्रश्न
Can I take Exenatide injectable with Insulin glargine-lixisenatide?
MediHelp rates the interaction as major. Exenatide injectable and Insulin glargine-lixisenatide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both products are GLP-1 receptor agonists (lixisenatide in the fixed-dose combination and exenatide), so combining them duplicates therapy without a proven added benefit. Gastrointestinal adverse effects, and hypoglycemia from the insulin component, may be increased.
How serious is the interaction between Exenatide injectable and Insulin glargine-lixisenatide?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid using two GLP-1 receptor agonists together; choose a single agent and stop the duplicate. If the combination is unavoidable, monitor blood glucose and GI tolerability closely and reduce insulin as needed.
What other medicines interact with Insulin glargine-lixisenatide?
MediHelp also lists interactions of Insulin glargine-lixisenatide with, for example, Albiglutide, Chlorpropamide, Dulaglutide. The full list is on the Insulin glargine-lixisenatide page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
